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Introduction {#sec005}
============

Background {#sec006}
----------

Trauma is one of the major health problems worldwide. \[[@pone.0233838.ref001]\] In 2013, 973 million people were estimated to have experienced trauma, 56.2 million patients were admitted to the hospital due to trauma, and 8 million people died from trauma globally. \[[@pone.0233838.ref002]\] Therefore, prognostication in trauma care is of interest to physicians. While traditional risk scores, such as the Injury Severity Score (ISS), \[[@pone.0233838.ref003]\] Revised Trauma Score (RTS), \[[@pone.0233838.ref004]\] and TRauma and Injury Severity Score (TRISS) \[[@pone.0233838.ref005]\] are widely used, researchers have been keen to identify more prognostic factors in trauma patients.

Platelet-to-lymphocyte ratio (PLR) has emerged as a prognostic marker in various acute conditions, including sepsis, \[[@pone.0233838.ref006]\] myocardial infarction, \[[@pone.0233838.ref007]\] pulmonary embolism, \[[@pone.0233838.ref008]\] acute heart failure, \[[@pone.0233838.ref009]\] acute exacerbation of chronic obstructive pulmonary disease, \[[@pone.0233838.ref010],[@pone.0233838.ref011]\] gastrointestinal bleeding, \[[@pone.0233838.ref012]\] pancreatitis, \[[@pone.0233838.ref013]\] and diabetic ketoacidosis. \[[@pone.0233838.ref014]\] However, the literature on its use in trauma care is insufficient. PLR has been evaluated in low-energy trauma patients \[[@pone.0233838.ref015]\] and a small number of critically ill patients with severe trauma. \[[@pone.0233838.ref016]\] Therefore, the present study aimed to evaluate the prognostic value of PLR in predicting in-hospital mortality in patients involved in traffic accidents, which were considered as one of the main components of major trauma. \[[@pone.0233838.ref017],[@pone.0233838.ref018]\] We hypothesized that the initial PLR after arrival at the emergency department (ED) was associated with an increased risk of in-hospital mortality in admitted adult traffic accident patients.

Materials and methods {#sec007}
=====================

Study design and setting {#sec008}
------------------------

The present study was a retrospective chart review study and was approved by the institutional review board (IRB) of Chonbuk National University Hospital. The IRB waived the requirement for informed consent in the present study. The study hospital is a 1200-bed urban, academic, tertiary care, university hospital. The study hospital's ED is the largest referral center in the province. We referred to the Standards for the Reporting of Diagnostic Accuracy recommendations when analyzing the results. \[[@pone.0233838.ref019],[@pone.0233838.ref020]\] In the study hospital's ED, initial blood tests were usually performed within few minutes after presentation to the ED.

Selection of participants {#sec009}
-------------------------

The study hospital's ED is part of the Emergency Department-based Injury In-depth Surveillance (EDIIS). The EDIIS is a nationwide injury database that was developed and operated by the Korea Centers for Disease Control and Prevention. Among the patients who visited the study hospital's ED between January 1, 2016, and December 31, 2016, patients who were registered as involved in traffic accidents were screened. Among those, patients who were admitted to the study hospital were eligible for inclusion in the study. However, we excluded the following patients: (1) pediatric patients aged below 18 years and (2) patients who had no ED laboratory test results.

Data collection {#sec010}
---------------

The EDIIS database reports data on a total of 246 variables, which includes basic demographics, injury epidemiologic information, comorbidities, initially assessed clinical findings at ED, diagnosis, disposition at the ED, and patient outcome after admission. For the present study, data of the following variables were extracted: age, sex, emergency medical service (EMS) use, transfer from other hospitals or facilities, comorbidities (hypertension, diabetes mellitus, coronary artery disease, cerebrovascular disease, or malignancy), time to ED arrival, physiology at ED presentation (systolic blood pressure \[SBP\], diastolic blood pressure, heart rate, respiratory rate \[RR\], body temperature \[BT\], Glasgow Coma Scale \[GCS\] score), patient status (car vs. motorcycle vs. bicycle vs. pedestrian), counter status (car vs. motorcycle or bicycle status vs. object vs. unknown), injury site (brain, head/face/neck, chest, abdomen, extremity, spine), ISS, intensive care unit (ICU) admission, emergent operation, total operation, time to admission, time to hospital discharge after admission, and survival status at hospital discharge. Data on platelet and lymphocyte counts were also extracted. The initial platelet count and lymphocyte count after ED arrival were selected. RTS, TRISS, and PLR were calculated using the collected data.

Outcome measures {#sec011}
----------------

The primary outcome was in-hospital mortality.

Statistical analysis {#sec012}
--------------------

The data were analyzed for normal distribution of continuous variables using the Shapiro-Wilk test. Continuous data were presented as medians and interquartile ranges (IQRs) if they were distributed non-normally and as mean and standard deviation if they were distributed normally. Categorical data were presented as count and percentage.

Comparison of normally distributed data was performed using an independent sample t-test. For non-normally distributed data, comparisons were performed using the Mann-Whitney U test or Kruskal-Wallis test. For categorical data, the chi-squared test was performed. If necessary, a chi-squared test with a Fischer's exact test for 2×2 table was performed. Results were considered significant at a threshold of p\<0.05 (two-tailed). Differences were tested between the survivor group and non-survivor group and between PLR tertiles.

The predictive capacities of the PLR, platelet count, and lymphocyte count with regard to the primary outcome were assessed by area under the receiver operating characteristic (AUROC) curve analysis. The standard errors of the mean and p-values for the AUROC curves were calculated and compared using the methods proposed by Hanley and McNeil \[[@pone.0233838.ref021]\]. \[[@pone.0233838.ref019]\] Sensitivity (SN), specificity (SP), positive likelihood ratio (+LR), and negative likelihood ratio (-LR) were evaluated at a clinical cutoff value.

The variables that were found to be statistically associated with the primary outcome based on univariate analysis using Cox regression were entered into the multivariate regression models. Multivariate Cox hazard regression analysis was performed to determine the independent effect of PLR on the primary outcome. The results of the Cox regression analysis were reported as hazard ratios (HRs) and 95% confidence intervals (CIs). The Kaplan-Meier survival analysis was performed to show the cumulative survival for each PLR tertile.

To reduce imbalance and achieve comparable distribution of severity between survivors and non-survivors for an unbiased estimation of PLR on survival, we applied 1:1 statistical matching of survivors and non-survivors in a nested case-control setting. The ISS, RTS, and TRISS which are widely applied to measure the injury severity of trauma patients were included as matching variables. We considered both the time to death and censoring in the total data analysis, thus Cox hazard regression analysis was applied. While, logistic regression analysis was applied for this nested case-control study to propose significantly associated variables as general analysis for case-control study and the association between PLR and survival was confirmed again.

All analyses were performed using an R software package (version 3.4.3, 2015; R Core Team, Vienna, Austria), Stata 11.1 (StataCorp LP, TX, USA), and Statistical Analysis System (SAS) 9.1 (SAS Institute Inc., Cary, NC, USA).

Results {#sec013}
=======

In this study, 1,522 traffic accident patients were screened. Among them, 537 patients were admitted to the study hospital. A total of 44 pediatric patients and five patients with no ED laboratory test results were excluded. Finally, 488 patients were enrolled in the analysis ([Fig 1](#pone.0233838.g001){ref-type="fig"}).

![The Standards for the Reporting of Diagnostic Accuracy flow diagram for the study.](pone.0233838.g001){#pone.0233838.g001}

[Table 1](#pone.0233838.t001){ref-type="table"} shows the baseline characteristics of the enrolled patients before and after matching. Before matching, most patients were involved in car accidents (n = 234, 48.0%), followed by motorcycle accidents (n = 103, 21.1%), and pedestrian accidents (n = 99, 20.3%). Cars were most frequently encountered in the accidents (n = 263, 53.9%), followed by inanimate objects (n = 177, 36.3%). The extremity was the most frequent anatomical site (n = 226, 46.3%), followed by the spine (n = 172, 35.3%), head/face/neck (n = 149, 30.5%), brain (n = 143, 29.3%), chest (n = 138, 28.3%), and abdomen (n = 68, 13.9%). A total of 147 patients (30.1%) were admitted to the ICU, and 143 patients (29.3%) underwent emergent operation. The median platelet and lymphocyte counts were 222.5 (183.0, 265.0) and 1.8 (1.2, 3.0), respectively. The median PLR was 115.3 (71.3, 181.8).

10.1371/journal.pone.0233838.t001

###### Baseline characteristics of the enrolled patients, comparison between survivor and non-survivor groups, and 1:1 propensity score matching (PSM) of patients.
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  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variable               Total                   Total no. of patients   \                       Patients after PSM   \                                               
                                                                         p-value                                      p-value                                         
  ---------------------- ----------------------- ----------------------- ----------------------- -------------------- ----------------------- ----------------------- ---------
  Number                 488 (100%)              445 (91.2%)             43 (8.8%)                                    43 (50.0%)              43 (50.0%)              

  Age                    60 \[45.5;72.0\]        59.0 \[45.0;71.0\]      66.0 \[55.5;75.0\]      0.019                64.0 \[53.5;73.0\]      66.0 \[55.5;75.0\]      0.492

  Male sex               333 (68.2%)             303 (68.1%)             30 (69.8%)              0.957                27 (62.8%)              30 (69.8%)              0.648

  EMS use                266 (54.5%)             233 (52.4%)             33 (76.7%)              0.004                29 (67.4%)              33 (76.7%)              0.471

  Transfer               62 (12.7%)              60 (13.5%)              2 (4.7%)                0.155                4 (9.3%)                2 (4.7%)                0.672

  HTN                    134 (27.5%)             124 (27.9%)             10 (23.3%)              0.640                14 (32.6%)              10 (23.3%)              0.471

  DM                     61 (12.5%)              54 (12.1%)              7 (16.3%)               0.587                5 (11.6%)               7 (16.3%)               0.756

  CAD                    30 (6.2%)               27 (6.1%)               3 (7.0%)                1.000                2 (4.7%)                3 (7.0%)                1.000

  CVA                    24 (4.9%)               23 (5.2%)               1 (2.3%)                0.650                6 (14.0%)               1 (2.3%)                0.115

  Malignancy             23 (4.7%)               21 (4.7%)               2 (4.7%)                1.000                1 (2.3%)                2 (4.7%)                1.000

  Time to ED, min        83 \[40.5;208.0\]       92 \[44;215\]           38 \[26.5;101.5\]       \<0.001              54.0 \[37.0;122.5\]     38.0 \[26.5;101.5\]     0.111

  SBP                    130.0 \[110.0;150.0\]   130.0 \[113.0;150.0\]   95.0 \[70.0;125.0\]     \<0.001              110.0 \[78.5;130.0\]    95.0 \[70.0;125.0\]     0.132

  DBP                    78.0 \[50.6;90.0\]      80.0 \[67.0;90.0\]      60.0 \[45.0;80.0\]      \<0.001              70.0 \[50.0;80.0\]      60.0 \[45.0;80.0\]      0.123

  PR                     84.0 \[74.0;95.5\]      84.0 \[74.0;94.0\]      90.0 \[75.0;113.5\]     0.045                84.0 \[73.5;106.0\]     90.0 \[75.0;113.5\]     0.551

  RR                     18.0 \[18.0;20.0\]      18.0 \[18.0;20.0\]      18.0 \[18.0;20.5\]      0.871                18.0 \[18.0;21.0\]      18.0 \[18.0;20.5\]      0.721

  BT                     36.5 \[36.1;36.9\]      36.5 \[36.2;36.9\]      36.0 \[35.5;36.5\]      \<0.001              36.0 \[36.0;36.5\]      36.0 \[35.5;36.5\]      0.238

  GCS                    15.0 \[15.0;15.0\]      15.0 \[15.0;15.0\]      7.0 \[3.0;13.5\]        \<0.001              11.0 \[6.0;15.0\]       7.0 \[3.0;13.5\]        0.045

  Patient status                                                                                 0.054                                                                0.889

      Car                234 (48.0%)             222 (49.9%)             12 (27.9%)                                   14 (32.6%)              12 (27.9%)              

      Motorcycle         103 (21.1%)             90 (20.2%)              13 (30.2%)                                   14 (32.6%)              13 (30.2%)              

      Bicycle            52 (10.7%)              46 (10.3%)              6 (14.0%)                                    4 (9.3%)                6 (14.0%)               

      Pedestrian         99 (20.3%)              87 (19.6%)              12 (27.9%)                                   11 (25.6%)              12 (27.9%)              

  Counter status                                                                                 0.077                                                                0.078

      Car                263 (53.9%)             232 (52.1%)             31 (72.1%)                                   22 (51.2%)              31 (72.1%)              

      Motor or bicycle   7 (1.4%)                7 (1.6%)                0 (0.0%)                                     0 (0.0%)                0 (0.0%)                

      Object             177 (36.3%)             165 (37.1%)             12 (27.9%)                                   19 (44.2%)              12 (27.9%)              

      Unknown            41 (8.4%)               41 (9.2%)               0 (0.0%)                                     2 (4.7%)                0 (0.0%)                

  Injury site                                                                                                                                                         

      Brain              143 (29.3%)             115 (25.8%)             28 (65.1%)              \<0.001              33 (76.7%)              28 (65.1%)              0.342

      Head/Face/Neck     149 (30.5%)             144 (32.4%)             5 (11.6%)               0.008                20 (46.5%)              5 (11.6%)               0.001

      Chest              138 (28.3%)             119 (26.7%)             19 (44.2%)              0.025                14 (32.6%)              19 (44.2%)              0.375

      Abdomen            68 (13.9%)              50 (11.2%)              18 (41.9%)              \<0.001              10 (23.3%)              18 (41.9%)              0.107

      Extremity          226 (46.3%)             215 (48.3%)             11 (25.6%)              0.007                16 (37.2%)              11 (25.6%)              0.353

      Spine              172 (35.3%)             156 (35.1%)             16 (37.2%)              0.908                18 (41.9%)              16 (37.2%)              0.825

  ISS                    27.0 \[16.0;48.0\]      26.0 \[16.0;41.0\]      66.0 \[44.5;70.5\]      \<0.001              66.0 \[50.0;75.0\]      66.0 \[44.5;70.5\]      0.428

  RTS                    11.0 \[11.0;11.0\]      11.0 \[11.0;11.0\]      8.2 \[7.2;10.0\]        \<0.001              9.5 \[8.4;10.6\]        8.2 \[7.2;10.0\]        0.025

  TRISS                  99.0 \[95.2;99.8\]      99.3 \[97.1;99.8\]      60.0 \[17.7;83.8\]      \<0.001              72.8 \[54.4;82.6\]      60.0 \[17.7;83.8\]      0.107

  ICU admission          147 (30.1%)             106 (23.8%)             41 (95.3%)              \<0.001              31 (72.1%)              41 (95.3%)              0.009

  Emergent op            143 (29.3%)             113 (25.4%)             30 (69.8%)              \<0.001              17 (39.5%)              30 (69.8%)              0.009

  Total op               311 (63.7%)             279 (62.7%)             32 (74.4%)              0.127                29 (67.4%)              32 (74.4%)              0.635

  ED LOS, h              9.0 \[4.0;17.0\]        9.0 \[4.0;17.0\]        10.0 \[4.0;21.0\]       0.643                8.0 \[3.0;16.0\]        10.0 \[4.0;21.0\]       0.375

  Hospital LOS, days     13.0 \[7.0;26.0\]       14.0 \[8.0;27.0\]       2.0 \[1.0;8.0\]         \<0.001              38.0 \[16.0;68.5\]      2.0 \[1.0;8.0\]         \<0.001

  Platelets              222.5 \[183.0;265.0\]   227.0 \[188.0;265.0\]   183.0 \[141.0;230.0\]   \<0.001              198.0 \[157.0;265.0\]   183.0 \[141.0;230.0\]   0.021

  Lymphocytes            1.8 \[1.2;3.0\]         1.8 \[1.2;2.8\]         3.4 \[2.0;5.4\]         \<0.001              2.6 \[1.5;4.8\]         3.4 \[2.0;5.4\]         0.130

  PLR                    115.3 \[71.3;181.8\]    124.2 \[79.5;187.2\]    51.3 \[32.3;77.9\]      \<0.001              85.8 \[57.6;137.2\]     51.3 \[32.3;77.9\]      \<0.001
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations PSM, propensity score matching; EMS, emergency medical service; HTN, hypertension; DM, diabetes mellitus; CAD, coronary artery disease; CVA, cerebrovascular disease; ED, emergency department; SBP, systolic blood pressure; DBP, diastolic blood pressure; PR, pulse rate; RR, respiratory rate; BT, body temperature; GCS, Glasgow coma scale; ISS, injury severity scale; RTS, revised trauma score; TRISS, trauma and injury severity score; ICU, intensive care unit; op, operation; LOS, length of stay; PLR, platelet to lymphocyte ratio.

Those in the non-survivor group were older, used EMS more often, and arrived earlier from the scene to the ED than those in the survivor group. The initial ED physiological variables except RR were poor in the non-survivor group than that of the survivor group. In-hospital mortality rates were the highest for motorcycle accidents, followed by car and pedestrian accidents. The non-survivor group showed a higher prevalence of brain, chest, and abdominal injuries and lower prevalence of head/face/neck and extremity injuries than the survivor group. The risk scores, including ISS, RTS, and TRISS, worse in the non-survivor group than in the survivor group. The platelet count was lower and lymphocyte count was higher in the non-survivor group than in the survivor group. The PLR was lower in the non-survivor group than in the survivor group (51.3 \[32.3, 77.9\] vs. 124.2 \[79.5, 187.2\], p\<0.001).

PLR ranged from 21.5 to 972.2. For further analysis, PLR was divided into tertile. The cutoff values were 85.6 and 156.2. The in-hospital mortality rates of the 1^st^, 2^nd^, and 3^rd^ tertile were 21.5% (35/163), 2.5% (4/163), and 2.5% (4/162), respectively. The in-hospital mortality rate of the 1st tertile was significantly higher than the rates of the 2^nd^ and 3^rd^ tertiles (both p \< 0.001) ([Fig 2](#pone.0233838.g002){ref-type="fig"}). When the PLR was below 85.6, the SN, SP, +LR, and -LR were 90.7%, 35.5%, 1.41, and 0.26, respectively.

![In-hospital mortality according to tertile of platelet-to-lymphocyte ratio (PLR).](pone.0233838.g002){#pone.0233838.g002}

After matching for ISS, RTS, and TRISS, most of the characteristics between the survivors and non-survivors were comparable, except GCS score, injury site for head/face/neck, RTS, ICU admission, emergent operation, hospital LOS, platelet count, and PLR which was our target variable ([Table 1](#pone.0233838.t001){ref-type="table"}).

The AUROC value of PLR for in-hospital survival was 0.82 (95% CI, 0.74--0.89). The AUROC values of platelet count and lymphocyte count for in-hospital mortality were 0.67 (0.57--0.76) and 0.72 (0.63--0.81), respectively. The AUROC value of PLR was significantly higher than those of platelet count (p = 0.001) and lymphocyte count (p = 0.033). There was no significant difference between the AUROC values of platelet and lymphocyte counts (p = 0.251).

The multivariate Cox regression models ([Table 2](#pone.0233838.t002){ref-type="table"}), adjusted for age, EMS use, SBP, RR, BT, GCS score, patient status, injury site, ISS, RTS, TRISS, ICU admission, and emergent operation, revealed that the 2^nd^ tertile of PLR was independently predictive of in-hospital mortality (AHR, 0.30 \[0.09--0.98\]; p = 0.047). Age, abdominal injury, ICU admission, and emergent operation remained significant variables. The Kaplan-Meier survival analysis showed a significant difference between tertiles (log-rank test p \< 0.001) ([Fig 3](#pone.0233838.g003){ref-type="fig"}). After propensity score matching, the 2^nd^ tertile of PLR was found to remain an independently associated factor of in-hospital mortality with a similar HR as that in the total population (AOR, 0.21 \[0.05--0.97\]; p = 0.046). Other variables, except injury site and emergent operation which showed a significant association with in-hospital mortality in the total population were not significant in the matched population ([Table 3](#pone.0233838.t003){ref-type="table"}).

![Kaplan-Meier survival curves according to tertiles of platelet-to-lymphocyte ratio (PLR).](pone.0233838.g003){#pone.0233838.g003}

10.1371/journal.pone.0233838.t002

###### Cox hazard regression analysis for the total number of patient.
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  Variable                                   Unadjusted hazard ratio   p-value   Adjusted hazard ratio   p-value
  ------------------------------------------ ------------------------- --------- ----------------------- ---------
  Age                                        1.02 (1.00--1.04)         0.058     1.05 (1.01--1.08)       0.014
  Male sex                                   1.05 (0.55--2.01)         0.883                             
  EMS use                                    2.63 (1.29--5.36)         0.008     2.05 (0.85--4.96)       0.112
  Transferred                                0.34 (0.08--1.40)         0.134                             
  HTN                                        0.79 (0.39--1.60)         0.507                             
  DM                                         1.27 (0.57--2.86)         0.561                             
  CAD                                        1.24 (0.38--4.00)         0.724                             
  CVA                                        0.43 (0.06--3.11)         0.401                             
  Malignancy                                 1.08 (0.26--4.49)         0.912                             
  Time to ED, min                            1.00 (1.00--1.00)         0.301                             
  SBP                                        0.97 (0.97--0.98)         \<0.001   1.00 (0.98--1.01)       0.546
  DBP[\*](#t002fn002){ref-type="table-fn"}   0.96 (0.95--0.97)         \<0.001   Omitted                 
  PR                                         1.01 (0.99--1.02)         0.303                             
  RR                                         0.88 (0.82--0.93)         \<0.001   1.07 (0.92--1.23)       0.378
  BT                                         0.91 (0.88--0.94)         \<0.001   1.00 (0.94--1.07)       0.929
  GCS                                        0.75 (0.70--0.80)         \<0.001   0.94 (0.79--1.13)       0.519
  Patient                                                                                                
      Car                                    Reference                           Reference               
      Motorcycle                             2.43 (1.11--5.32)         0.027     1.08 (0.41--2.84)       0.884
      Bicycle                                2.39 (0.89--6.39)         0.082     1.01 (0.28--3.70)       0.986
      Pedestrian                             2.12 (0.95--4.76)         0.068     1.46 (0.57--3.79)       0.432
  Counter                                                                                                
      Car                                    Reference                                                   
      Motor or bicycle                       Omitted                                                     
      Object                                 0.60 (0.31--1.18)         0.138                             
      Unknown                                Omitted                                                     
  Injury site                                                                                            
      Brain                                  4.17 (2.22--7.84)         \<0.001   1.81 (0.63--5.22)       0.271
      Head/Face/Neck                         0.29 (0.12--0.75)         0.010     0.47 (0.16--1.41)       0.179
      Chest                                  1.97 (1.07--3.60)         0.028     1.20 (0.49--2.93)       0.690
      Abdomen                                4.70 (2.54--8.68)         \<0.001   3.80 (1.50--9.64)       0.005
      Extremity                              0.35 (0.18--0.70)         0.003     0.78 (0.30--2.05)       0.617
      Spine                                  1.08 (0.58--2.01)         0.807                             
  ISS                                        1.06 (1.04--1.07)         \<0.001   1.01 (0.97--1.05)       0.589
  RTS                                        0.68 (0.63--0.73)         \<0.001   0.71 (0.41--1.26)       0.250
  TRISS                                      0.96 (0.95--0.97)         \<0.001   1.01 (0.98--1.04)       0.615
  ICU admission                              46.2 (11.1--191.2)        \<0.001   6.66 (1.30--34.13)      0.023
  Emergent op                                5.26 (2.73--10.12)        \<0.001   2.84 (1.24--6.54)       0.014
  Total op                                   1.34 (0.67--2.68)         0.406                             
  ED LOS, h                                  1.00 (0.98--1.03)         0.774                             
  Platelets                                  0.99 (0.99--0.99)         \<0.001   Omitted                 
  Lymphocytes                                1.52 (1.32--1.75)         \<0.001   Omitted                 
  PLR                                        0.98 (0.97--0.99)         \<0.001   Omitted                 
  PLR 1^st^ tertile                          Reference                           Reference               
  PLR 2^nd^ tertile                          0.12 (0.04--0.33)         \<0.001   0.30 (0.09--0.98)       0.047
  PLR 3^rd^ tertile                          0.12 (0.04--0.33)         \<0.001   0.71 (0.20--2.53)       0.596

Abbreviations EMS, emergency medical service; HTN, hypertension; DM, diabetes mellitus; CAD, coronary artery disease; CVA, cerebrovascular disease; ED, emergency department; SBP, systolic blood pressure; DBP, diastolic blood pressure; PR, pulse rate; RR, respiratory rate; BT, body temperature; GCS, Glasgow coma scale; ISS, injury severity scale; RTS, revised trauma score; TRISS, trauma and injury severity score; ICU, intensive care unit; op, operation; LOS, length of stay; PLR, platelet to lymphocyte ratio.

\* DBP showed high collinearity with SBP.

10.1371/journal.pone.0233838.t003

###### Logistic regression analysis of the 1:1 propensity score matched patients.
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  Variable                                   Unadjusted odd ratio   p-value   Adjusted odd ratio   p-value
  ------------------------------------------ ---------------------- --------- -------------------- ---------
  Age                                        1.01 (0.98--1.03)      0.547                          
  Male sex                                   1.37 (0.56--3.36)      0.494                          
  EMS use                                    1.59 (0.61--4.13)      0.338                          
  Transferred                                0.48 (0.08--2.75)      0.406                          
  HTN                                        0.63 (0.24--1.63)      0.338                          
  DM                                         1.48 (0.43--5.08)      0.535                          
  CAD                                        1.54 (0.24--9.69)      0.647                          
  CVA                                        0.15 (0.02--1.28)      0.082     0.13 (0.01--1.60)    0.111
  Malignancy                                 1.00 (0.13--7.44)      1.000                          
  Time to ED, min                            1.00 (1.00--1.00)      0.603                          
  SBP                                        0.99 (0.98--1.00)      0.081     0.99 (0.98--1.01)    0.520
  DBP[\*](#t003fn002){ref-type="table-fn"}   0.98 (0.97--1.00)      0.073     Omitted              
  PR                                         1.00 (0.99--1.01)      0.801                          
  RR                                         0.93 (0.83--1.04)      0.183                          
  BT                                         0.83 (0.48--1.43)      0.504                          
  GCS                                        0.92 (0.84--1.01)      0.066     1.04 (0.83--1.31)    0.720
  Patient status                                                                                   
      Car                                    Reference                                             
      Motorcycle                             1.38 (0.30--6.20)      0.679                          
      Bicycle                                0.85 (0.28--2.59)      0.777                          
      Pedestrian                             0.79 (0.26--2.42)      0.674                          
  Counter status                                                                                   
      Car                                    Reference                                             
      Motor or bicycle                       Omitted                                               
      Object                                 0.45 (0.18--1.11)      0.083     0.31 (0.08--1.20)    0.091
      Unknown                                Omitted                                               
  Injury site                                                                                      
      Brain                                  0.57 (0.22--1.46)      0.238                          
      Head/Face/Neck                         0.15 (0.05--0.46)      0.001     0.11 (0.02--0.55)    0.007
      Chest                                  1.64 (0.68--3.94)      0.269                          
      Abdomen                                2.38 (0.94--6.03)      0.069     1.65 (0.43--6.34)    0.467
      Extremity                              0.58 (0.23--1.46)      0.247                          
      Spine                                  0.82 (0.35--1.96)      0.659                          
  ISS                                        0.99 (0.96--1.02)      0.409                          
  RTS                                        0.75 (0.59--0.95)      0.019     0.93 (0.52--1.65)    0.796
  TRISS                                      0.98 (0.97--1.00)      0.038     1.00 (0.97--1.02)    0.687
  ICU admission                              7.94 (1.65--38.06)     0.010     3.57 (0.43--29.91)   0.241
  Emergent op                                3.53 (1.45--8.62)      0.006     3.81 (1.07--13.55)   0.039
  Total op                                   1.40 (0.55--3.58)      0.477                          
  ED LOS, h                                  1.03 (0.98--1.09)      0.197                          
  Platelets                                  0.99 (0.99--1.00)      0.017     Omitted              
  Lymphocytes                                1.20 (0.97--1.49)      0.101     Omitted              
  PLR                                        0.99 (0.98--1.00)      0.016     Omitted              
  PLR 1^st^ tertile                          Reference                        Reference            
  PLR 2^nd^ tertile                          0.16 (0.05--0.55)      0.003     0.21 (0.05--0.97)    0.046
  PLR 3^rd^ tertile                          0.34 (0.09--1.31)      0.118     2.33 (0.31--17.78)   0.415

Abbreviations EMS, emergency medical service; HTN, hypertension; DM, diabetes mellitus; CAD, coronary artery disease; CVA, cerebrovascular disease; ED, emergency department; SBP, systolic blood pressure; DBP, diastolic blood pressure; PR, pulse rate; RR, respiratory rate; BT, body temperature; GCS, Glasgow coma scale; ISS, injury severity scale; RTS, revised trauma score; TRISS, trauma and injury severity score; ICU, intensive care unit; op, operation; LOS, length of stay; PLR, platelet to lymphocyte ratio.

\* DBP showed high collinearity with SBP.

Discussion {#sec014}
==========

The present study found that PLR is an independent predictive marker in adult traffic accident patients. Even after propensity score matching, PLR showed significance, despite the small sample size. To the best of our knowledge, this is the first study that evaluates the predictive value of PLR in adult traffic accident patients, which is considered as one of the main components of major trauma.

Trauma results in significant morbidity and mortality, which warrants the risk prediction for the trauma patients. The well-used risk scores such as the ISS, RTS, and TRISS are based on physiology and injury site. Moreover, several laboratory markers have been tested for their prognostic value for mortality such as hemoglobin, creatinine, pH, base excess, activated partial thromboplastin time, prothrombin time/international normalized ratio, and lactate. \[[@pone.0233838.ref022], [@pone.0233838.ref023]\] Recently, new risk scoring systems that incorporate physiology and laboratory markers have been introduced. \[[@pone.0233838.ref022], [@pone.0233838.ref024]\]

There are notable advantages of using PLR. PLR is very simple and easy to calculate. Furthermore, PLR can be used in almost all EDs worldwide, including those in developing countries, because the complete blood count (CBC) test is widely used and is very cheap. Moreover, CBC can be determined rapidly. The time taken per analysis is a few minutes when using recent commercial automated hematology analyzers. Thus, PLR can be available in the early phase while treating acutely ill patients. Thus, several studies have been conducted to determine the predictive performance of PLR in various acute illnesses.

We found significant gaps in mortality rates between PLR tertiles (21.5% at the 1^st^ tertile vs. 2.5% each at the 2^nd^ and 3^rd^ tertiles). The Kaplan-Meier curve showed that the gap in mortality rates was predominant in the early phase (in 10 days). Furthermore, PLR was significantly associated with in-hospital mortality after adjusting for the baseline characteristics, comorbidities, physiology, injury site, and traditional risk scores. Even the ISS, RTS, and TRISS became insignificant in the multivariate Cox regression model.

Platelets play a key role in hemostasis; they rapidly bind to damaged blood vessels and aggregate to form thrombi, thus preventing excessive bleeding. \[[@pone.0233838.ref025], [@pone.0233838.ref026]\] Moreover, platelets play an important role in the development of sepsis. \[[@pone.0233838.ref027]\] Platelet activation leads to endothelial injury and promotes neutrophil extracellular trap and microthrombi formation. This exacerbates septic coagulation and inflammatory reactions. Furthermore, disseminated intravascular coagulation leads to multi-organ dysfunction syndrome (MODS). Some studies have suggested a direct link between low platelet count and MODS in trauma patients. \[[@pone.0233838.ref028], [@pone.0233838.ref029]\] Additionally, some studies have suggested that platelets induce the release of inflammatory cytokines \[[@pone.0233838.ref030]\] and interact with neutrophils, T cells, and macrophages. \[[@pone.0233838.ref031]\]

Lymphocytes are the major cellular components of the humoral and cell-mediated immune system and include T cell, B cells, and natural killer cells. \[[@pone.0233838.ref032]\] The immune competence of lymphocytes is negatively modulated after trauma or hemorrhage, and a decrease in lymphocyte counts is associated with the development of sepsis and MODS among trauma patients. \[[@pone.0233838.ref033]--[@pone.0233838.ref035]\] The normal range of PLR has not been confirmed yet, but the mean PLR in healthy adults in South Korea is reported to be 132.40 ± 43.68. \[[@pone.0233838.ref036]\] The reference ranges for platelet and lymphocyte counts are 150,000 to 450,000 and 1.0 to 3.0, respectively. In the present study, the 1st tertile of PLR (\<85.6) showed significantly higher mortality than the other two tertiles. The median values of platelet and lymphocyte counts in enrolled patients, the survivor group, and the non-survivor group were within the reference ranges, except in the case of lymphocyte counts in the non-survivor group. Platelet counts were significantly lower in the non-survivor group than those in the survivor group; on the contrary, lymphocyte counts were significantly higher in the non-survivor group than those in the survivor group. The Kaplan-Meier curve showed that a survival gap between the groups was predominant within several days after trauma. Thus, we hypothesized that the notable prognostic value of PLR, which is significantly higher than both platelet and lymphocyte counts, was a comprehensive reflection of the extent to which the trauma affected the two variables (platelet and lymphocyte counts).

Recently, few studies have evaluated the PLR performance in trauma patients. Emektar et al. investigated the effect of PLR at hospital admission on 1-year mortality in 560 elderly patients with hip fractures. \[[@pone.0233838.ref015]\] The platelet count was similar between the non-survivor and survivor groups (214 \[IQR, 172--257\] vs. 206 \[159--263\], p = 0.3). The lymphocyte count was lower in the non-survivor group than in the survivor group (1.0 \[IQR, 0.7--1.4\] vs. 1.2 \[0.9--1.6\], p = 0.004). PLR was higher in the non-survivor group than in the survivor group (197 \[IQR, 140--289\] vs. 178 \[119--248\], p = 0.02). These findings are contrary to our findings. In our study, the platelet count was lower, lymphocyte count was higher, and PLR was lower in the non-survivor group than in the survivor group. However, the Cox regression model in the study by Emektar et al. showed an adjusted HR of less than 1.0 (0.997 \[95% CI, 0.994--0.999\]), which seems to be consistent with our findings.

Djordjevic et al. evaluated the predictive value of PLR on surgical ICU admission among 392 critically ill and injured patients. \[[@pone.0233838.ref016]\] In this study, critically ill patients with severe trauma were defined as having an ISS \> 25. The cohort was relatively heterogeneous because the patients had different diseases, including peritonitis, pancreatitis, and trauma with or without sepsis. Hence, only a small number of patients (n = 46) formed the trauma subgroup. PLR was higher in the non-survivor group (378.19 \[IQR, 237.35--574.38 vs. 220.33 \[143.39--315.17\], p = 0.029) than in the survivor group. There were 83 patients in the trauma with sepsis subgroup. PLR was not significantly different in the non-survivor group (246.08 \[IQR, 162.22--373.41\] vs. 198.60 \[145.80--336.45\], p = 0.356). The odds ratio or HR of PLR in the trauma subgroup or the trauma with sepsis subgroup was not documented.

This study has some limitations. First, this was a retrospective chart review study conducted in a single center. The reproducibility and generalizability of the results should be tested in a larger study. Second, there could be unknown confounding factors. We adjusted for baseline characteristics, comorbidities, physiological variables, traffic accident mechanisms, and risk scores in the regression model. However, other potential laboratory biomarkers may eliminate the significance of PLR for the outcome. \[[@pone.0233838.ref022], [@pone.0233838.ref023]\] Despite of propensity matching between survivors and non-survivors to identify the independent effect of PLR, a few variables still showed different distribution--GCS score, head/face/neck, RTS, TRISS, ICU admission, emergency operation, and platelet count. RTS, a variable considered in matching, showed a significant difference between the survivors and non-survivors, despite the absolute differences between the two groups being reduced. This point reflected that the characteristics between the two groups were much different and could not be perfectly matched. This would be inevitable considering death as a fatal outcome. The purpose of this study was to investigate the independent association between PLR and in-hospital mortality, and adjusting for variables with significant differences could resolve the differences between the two groups, despite the possibility of residual confounding factors. Third, the severity of the enrolled patients can be concern of interest. We enrolled the adult traffic accident patients, but nearly half of them (45.5%) did not use EMS to arrive the ED. And considerable difference was found regarding the EMS use (52.4% in survivor group vs. 76.7% in non-survivor group). Even though PLR performance have been assured through the propensity matching analysis in which the EMS use was controlled well, severity of the enrolled patients may be still questioned, therefore, the immune and inflammatory response may be questioned as well. Unfortunately, the present study could not exclude the patients who did not use EMS because it resulted in a large reduction of a cohort. Further large study is needed to confirm the PLR performance.

In conclusion, PLR was significantly associated with an increased risk of in-hospital mortality in admitted adult traffic accident patients. Additionally, PLR had a better prognostic value than relative thrombocytopenia or lymphocytosis. PLR can be used as a readily usable prognostic parameter with no additional cost in clinical practice. Further studies are needed to evaluate the clinical role of PLR in different experiences and in different populations.

We wish to thank Yujin Jo for assistance with data collection.

[^1]: **Competing Interests:**The authors have declared that no competing interests exist.
